Back
DoubleLine Fortune 500 Equal Weight ETF Vs. Korro Bio Industry Stock Comparison
Buy
80
DFVE
DoubleLine Fortune 500 Equal Weight ETF
Last Price:
29.81
Seasonality Move:
--
Sell
47
KRRO
Korro Bio
Last Price:
54.01
Seasonality Move:
51.42%
Buy
80
DoubleLine Fortune 500 Equal Weight ETF (DFVE)
is a Buy
Is DoubleLine Fortune 500 Equal Weight ETF a Buy, Sell or Hold?
- The current DoubleLine Fortune 500 Equal Weight ETF [DFVE] share price is $29.78. The Score for DFVE is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- DFVE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Korro Bio (KRRO)
is a Sell
Is Korro Bio a Buy, Sell or Hold?
- The current Korro Bio [KRRO] share price is $55.01. The Score for KRRO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- KRRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DFVE Stock Price Chart
What is DoubleLine Fortune 500 Equal Weight ETF's stock price today?
-
The DoubleLine Fortune 500 Equal Weight ETF share price today is $29.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DFVE is experiencing selling pressure, which indicates risk of future bearish movement.
KRRO Stock Price Chart
DFVE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 63.41 | Buy |
| Chaikin Money Flow: | -3779 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.69 - 29.61) | Buy |
| Bollinger Bands (100): | (27.07 - 29.01) | Buy |
KRRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.92 | Buy |
| Relative Strength Index (14 RSI): | 44.75 | Sell |
| Chaikin Money Flow: | -239219 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.47 - 75.21) | Sell |
| Bollinger Bands (100): | (33.91 - 58.81) | Buy |
DFVE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.52 | Buy |
| 20-day SMA: | 29.16 | Buy |
| 50-day SMA: | 28.78 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 29.57 | Buy |
| 20-day EMA: | 29.25 | Buy |
| 50-day EMA: | 28.81 | Buy |
| 200-day EMA: | 8.38 | Buy |
KRRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.77 | Sell |
| 20-day SMA: | 66.99 | Sell |
| 50-day SMA: | 49.78 | Buy |
| 200-day SMA: | 51.83 | Buy |
| 8-day EMA: | 64.4 | Sell |
| 20-day EMA: | 62.15 | Sell |
| 50-day EMA: | 54.74 | Buy |
| 200-day EMA: | 49.56 | Buy |
DoubleLine Fortune 500 Equal Weight ETF Earnings Growth & DFVE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Korro Bio Earnings Growth & KRRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.16 per share, and a decrease next year of $0.40 per share.
DoubleLine Fortune 500 Equal Weight ETF Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Korro Bio Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||